These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6481014)

  • 1. Studies on the possible mechanisms of lidoflazine arrhythmogenicity.
    Keren G; Tepper D; Butler B; Maguire W; Willens H; Miura D; Somberg JC
    J Am Coll Cardiol; 1984 Oct; 4(4):742-7. PubMed ID: 6481014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the proarrhythmic action of lidoflazine (Clinium).
    Fazekas T; Szekeres L
    Acta Physiol Hung; 1990; 75(3):229-36. PubMed ID: 2392945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in serum digoxin concentration produced by quinidine does not increase the potential for digoxin-induced ventricular arrhythmias in dogs.
    Wilkerson RD; Beck BL
    J Pharmacol Exp Ther; 1987 Feb; 240(2):548-53. PubMed ID: 3806410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of lidoflazine and quindine in prophylactic treatment of arrhythmias.
    Kennelly BM
    Br Heart J; 1977 May; 39(5):540-6. PubMed ID: 324502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular arrhythmias associated with lidoflazine: side-effects observed in a randomized trial.
    Hanley SP; Hampton JR
    Eur Heart J; 1983 Dec; 4(12):889-93. PubMed ID: 6363079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver ultrastructure of dogs treated with lidoflazine for 4 years.
    Borgers M; Verheyen A; Marsboom R
    Toxicol Appl Pharmacol; 1975 Aug; 33(2):376-9. PubMed ID: 1179440
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction in digitalis-associated postinfarction mortality with nadolol in conscious dogs.
    Lynch JJ; Kitzen JM; Hoff PT; Lucchesi BR
    Am Heart J; 1988 Jan; 115(1 Pt 1):67-76. PubMed ID: 3336987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiotoxic interaction of metabolites from a prodrug segment cilexetil (cyclohexyloxy-carbonyloxy-ethyl) with digoxin in the canine failing heart.
    Okunishi H; Shimoura K; Wang DQ; Kakizoe E
    Pharmacol Res; 2002 Oct; 46(4):301-10. PubMed ID: 12361690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of lidoflazine on the excitation process in the resting and stress ECG in coronary patients (author's transl)].
    Lehmann HU; Scholle J; Hochrein H
    MMW Munch Med Wochenschr; 1974 Nov; 116(46):2019-26. PubMed ID: 4141058
    [No Abstract]   [Full Text] [Related]  

  • 10. Facilitation of lethal ventricular arrhythmias by therapeutic digoxin in conscious post infarction dogs.
    Lynch JJ; Montgomery DG; Lucchesi BR
    Am Heart J; 1986 May; 111(5):883-90. PubMed ID: 3706108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of intravenous lidoflazine on serotonin-induced cerebral vascular contraction--an in vivo study.
    Rosenwasser RH; Tuma RF; Buchheit WA
    Stroke; 1986; 17(4):728-30. PubMed ID: 3738957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute effect of lidoflazine on the electrocardiographic agitation discharge in atrial frequency stimulation (studies on patients with stress-induced coronary insufficiency)].
    Lehmann HU; Beck OA; Hochrein H
    Z Kardiol; 1975 May; 64(5):396-410. PubMed ID: 1189535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of lidoflazine on contractions of isolated canine coronary arteries caused by norepinephrine, 5-hydroxytryptamine, high potassium, anoxia and ergonovine maleate.
    Van Neuten JM; Van Beek J; Vanhoutte PM
    J Pharmacol Exp Ther; 1980 Apr; 213(1):179-87. PubMed ID: 7359366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of lidoflazine on cerebral blood flow following twelve minutes total cerebral ischemia.
    Dean JM; Hoehner PJ; Rogers MC; Traystman RJ
    Stroke; 1984; 15(3):531-5. PubMed ID: 6427983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lidoflazine on cerebral blood flow and neurologic outcome when administered after complete cerebral ischemia in dogs.
    Fleischer JE; Lanier WL; Milde JH; Michenfelder JD
    Anesthesiology; 1987 Mar; 66(3):304-11. PubMed ID: 3826688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Centrally mediated effect of phenytoin on digoxin-induced ventricular arrhythmias.
    Garan H; Ruskin JN; Powell WJ
    Am J Physiol; 1981 Jul; 241(1):H67-72. PubMed ID: 7246790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral ischemia and reperfusion: prevention of brain mitochondrial injury by lidoflazine.
    Rosenthal RE; Hamud F; Fiskum G; Varghese PJ; Sharpe S
    J Cereb Blood Flow Metab; 1987 Dec; 7(6):752-8. PubMed ID: 3693430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lidoflazine in the early stages of acute myocardial ischaemia.
    Coker SJ; Fagbemi O; Parratt JR
    Br J Pharmacol; 1982 Jun; 76(2):347-54. PubMed ID: 7093589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the Ca2+ antagonist lidoflazine on normoxic and anoxic contractions of canine coronary arterial smooth muscle.
    van Nueten JM; Vanhoutte PM
    Eur J Pharmacol; 1980 Jun; 64(2-3):173-6. PubMed ID: 7398761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trazodone-digoxin interaction in an animal model.
    Dec GW; Jenike MA; Stern TA
    J Clin Psychopharmacol; 1984 Jun; 4(3):153-5. PubMed ID: 6736275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.